Status:
ENROLLING_BY_INVITATION
Intraoperative Subanesthetic Ketamine Versus Dexmedetomidine Infusion for Prevention of Post-traumatic Stress Disorder After Traumatic Brain Surgeries
Lead Sponsor:
Zagazig University
Conditions:
Subanesthetic Ketamine Dexmedetomidin
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Prevention of Post-traumatic Stress Disorder after traumatic Brain surgeries by using either subanesthetic ketamine or dexmedetomidine infusion.
Detailed Description
after being informed about the study and potential risks. All patients giving written consent will be randomized by double blind manner into two equal groups (K group and D group). Using computer gene...
Eligibility Criteria
Inclusion
- Aged 18-60 years old.Body mass index of less than or equal 35.American Society of I and II.Duration of surgery not more than 3 hours.
Exclusion
- Known hypersensitivity to dexmedetomidine or ketamine. Hemorrhagic shock decompensation.History of alcohol or drug abuse.History of neurologic or psychiatric diseases Advanced renal ,liver or cardiovascular disorders.
Key Trial Info
Start Date :
July 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 15 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06498700
Start Date
July 15 2024
End Date
March 15 2025
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine,Zagazig University
Zagazig, Sharqia Province, Egypt, 44519